Literature DB >> 2521490

Clearance of atrial natriuretic factor by lung, liver, and kidney in human subjects and the dog.

A S Hollister1, R J Rodeheffer, F J White, J R Potts, T Imada, T Inagami.   

Abstract

We determined human and canine plasma clearance of atrial natriuretic factor (ANF) by lung, liver, and kidney from arteriovenous differences in plasma ANF and measured organ plasma flow. Human subjects had lower plasma ANF concentrations in the pulmonary vein or the pulmonary capillary wedge position when compared with the pulmonary artery, and both sites yielded pulmonary ANF extraction ratios of 24%. Canine lung ANF extraction was 19 +/- 3% and pulmonary ANF clearance was 328 +/- 78 ml/min per m2 vs. 357 +/- 53 ml/min per m2 in man. Hepatic plasma ANF clearance was 216 +/- 26 ml/min with an extraction ratio of 30 +/- 3% in humans and 199 +/- 89 ml/min and 36 +/- 6% in the dog. Renal plasma ANF clearance in human subjects was 78 +/- 12 ml/min per kidney and correlated well with each kidney's creatinine clearance (r = 0.58, P less than 0.05). The mean renal ANF extraction ratio was 35 +/- 4% in human subjects and 42 +/- 6% in the dog. These data quantitate the specific organ ANF clearances by lung, liver, and kidney in human subjects and in dogs and provide a rationale for elevated plasma ANF levels in cirrhosis, renal failure, and diseases accompanied by reduced perfusion of these organs. These findings support the conclusion that plasma ANF concentrations are dependent upon both the stimuli for ANF secretion as well as the specific organ clearances of ANF.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2521490      PMCID: PMC303723          DOI: 10.1172/JCI113926

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Plasma levels of atrial natriuretic peptide in patients with chronic liver disease.

Authors:  H Kawasaki; J Uemasu; N Maeda; C Hirayama; T Kobayashi; H Sakurai
Journal:  Am J Gastroenterol       Date:  1987-08       Impact factor: 10.864

2.  Inactivation of atrial natriuretic factor by the renal brush border.

Authors:  G M Olins; K L Spear; N R Siegel; H A Zurcher-Neely
Journal:  Biochim Biophys Acta       Date:  1987-07-10

3.  Organ extraction of atrial natriuretic peptide (ANP) in man. Significance of sampling site.

Authors:  H J Schütten; J H Henriksen; J Warberg
Journal:  Clin Physiol       Date:  1987-04

4.  Cardio-renal-endocrine dynamics during stepwise infusion of physiologic and pharmacologic concentrations of atrial natriuretic factor in the dog.

Authors:  R S Zimmerman; J A Schirger; B S Edwards; T R Schwab; D M Heublein; J C Burnett
Journal:  Circ Res       Date:  1987-07       Impact factor: 17.367

5.  Human atrial natriuretic peptide: plasma levels, hemodynamic, hormonal, and renal effects in patients with severe congestive heart failure.

Authors:  G A Riegger; E P Kromer; K Kochsiek
Journal:  J Cardiovasc Pharmacol       Date:  1986 Nov-Dec       Impact factor: 3.105

6.  Plasma alpha natriuretic peptide in cardiac impairment.

Authors:  A M Richards; J G Cleland; G Tonolo; G D McIntyre; B J Leckie; H J Dargie; S G Ball; J I Robertson
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-16

7.  Plasma levels of atrial natriuretic peptide in patients with chronic renal failure.

Authors:  K Hasegawa; Y Matsushita; T Inoue; H Morii; M Ishibashi; T Yamaji
Journal:  J Clin Endocrinol Metab       Date:  1986-10       Impact factor: 5.958

8.  Effect of haemodialysis on plasma concentrations of atrial natriuretic peptide in adult patients with chronic renal failure.

Authors:  J V Anderson; A E Raine; A Proudler; S R Bloom
Journal:  J Endocrinol       Date:  1986-08       Impact factor: 4.286

9.  Relationship between plasma atrial natriuretic peptide levels and atrial pressure in man.

Authors:  F Sato; K Kamoi; Y Wakiya; T Ozawa; O Arai; M Ishibashi; T Yamaji
Journal:  J Clin Endocrinol Metab       Date:  1986-10       Impact factor: 5.958

10.  Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.

Authors:  R J Cody; S A Atlas; J H Laragh; S H Kubo; A B Covit; K S Ryman; A Shaknovich; K Pondolfino; M Clark; M J Camargo
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

View more
  20 in total

1.  Atrial natriuretic peptide attenuates LPS-induced lung vascular leak: role of PAK1.

Authors:  Anna A Birukova; Junjie Xing; Panfeng Fu; Bakhtiyor Yakubov; Oleksii Dubrovskyi; Jennifer A Fortune; Alexander M Klibanov; Konstantin G Birukov
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-08-20       Impact factor: 5.464

2.  Opposite effects of ANP receptors in attenuation of LPS-induced endothelial permeability and lung injury.

Authors:  Junjie Xing; Bakhtiyor Yakubov; Valeriy Poroyko; Anna A Birukova
Journal:  Microvasc Res       Date:  2011-10-06       Impact factor: 3.514

3.  Localization of 125I-atrial natriuretic peptide (ANP) in the rat fetus.

Authors:  J N Scott; L Jennes
Journal:  Anat Embryol (Berl)       Date:  1991

4.  Atrial natriuretic factor secretion: a role for atrial systolic ejection force?

Authors:  B Geny; F Piquard; M Follenius; H Petit; F Levy; E Epailly; J G Kretz; B Eisenmann; P Haberey
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

Review 5.  Natriuretic peptide metabolism, clearance and degradation.

Authors:  Lincoln R Potter
Journal:  FEBS J       Date:  2011-04-07       Impact factor: 5.542

Review 6.  The renal paracrine peptide system--possible urologic implications of urodilatin.

Authors:  M Meyer; C G Stief; A J Becker; M C Truss; A Taher; U Jonas; W G Forssmann
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

7.  Kinetics of atrial natriuretic peptide in young and elderly subjects.

Authors:  A C Tan; T L Jansen; E F Termond; F G Russel; T Thien; P W Kloppenborg; T J Benraad
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 8.  Atrial natriuretic peptide. An overview of clinical pharmacology and pharmacokinetics.

Authors:  A C Tan; F G Russel; T Thien; T J Benraad
Journal:  Clin Pharmacokinet       Date:  1993-01       Impact factor: 6.447

9.  Changes in A-type natriuretic peptide and its receptors induced by a neutral endopeptidase inhibitor in a rat model of sepsis.

Authors:  Kanetaka Maeshiro; Shinzo Takamori; Hiroharu Mifune; Toshihiro Matsuo; Norman Y Kimura; Junichi Honda; Kazuo Shirouzu
Journal:  Surg Today       Date:  2008-02-01       Impact factor: 2.549

10.  Pulmonary and urinary clearance of atrial natriuretic factor in acute congestive heart failure in dogs.

Authors:  M A Perrella; K B Margulies; C M Wei; L L Aarhus; D M Heublein; J C Burnett
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.